The biotechnology sector is a paradigm of the knowledge economy where Human capital is at the basis of the creation of a collective intangible stock: science, expertise, creativity and self-confidence. These elements are the combination of the contributions attributable to each of the collaborators, and therefore, a stock that can be accumulated and used.
At ORYZON we are convinced that this Human Capital thus created benefits: